Hipertensión Arterial en el Adulto Mayor: una mirada actual. Primera parte (página 2)

32. Murgo WW, Westerhof N, Giolma JP, Altobelli SA. Aortic input impedance in normal men, relationship to pressure wave forms. Circulation. 2008;62:105-16.

33. Nichols WW, Rourke O', Avolio AP, Yaginuma T, Murgo JP, Pepine CJ. Effects of age on ventricular-vascular coupling. Am Journal Cardiologic. 2008;55:1179-84.

34. Latham RD, Westerhof N, Sipkema P, Rubal BJ, Reuderink P, Murgo JP. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. Circulation. 2005;72:1257-69.

35. Chen CH, Ting CT, Nussbacher A, Nevo E, Kass DA, Pak P, et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension. 1996;27:168-75.

36. Mayet J, Hughes A. Cardiac and vascular pathophysiology in hypertension. Heart. 2008:89;1104-9.

37. Rouleau J, Juneau C, Stephens H, Shenasa H, Parmley WW, Brutsaert DL. Mechanical properties of papillary muscle in cardiac failure: importance of pathogenesis and of ventricle of origin. Journal Mol Cell Cardiology. 1989:21:817-28.

38. Swynghedauw B. Molecular mechanisms of myocardial remodelling. Physiology Rev. 1999;79:215-62.

39.  Hansen-Smith F, Greene AS, Cowley AW, Lombard JH. Structural changes during microvascular rarefaction in chronic hypertension. Hipertensión. 2009;15:922-8.

40. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, et al. Phospate regulation of vascular smooth muscle cell calcification. Circ Res. 2007;27:10-17.

41. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension. 2007;43:163-8.

42. Veigh GE, Bratteli CW, Morgan DJ, Alinder CM Glasser SP, Finkeltein SM, et al. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis. Aging and arterial compliance. Hypertension. 1999;33:1392-8.

43. Weber KT. Aldosterone in congestive heart failure. New England Journal Medicine. 2007;345:1689-97.

44. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats. Circulation. 2007;106:2848-2853.

45. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al Coronary artery calcification in young adults with end stage renal disease who are undergoing dialysis. New England Journal Medical. 2007;342:1478-1483.

46. Yerkey MW, Kernis SJ, Franklin BA, Sandberg KR, McCullough PA. Renal dysfunction and acceleration of coronary disease. Herat. 2008;90:961-966.

47. Mikhail N, Golub MS, Tuc ML. Obesity and hypertensión. Program Cardiovasc Disease. 2009;42:39-58.

48. Sorof JM, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2007;441-447.

49. Whincup PH, Gilg JA, Donald AE. Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation. 2007;112:1798-1797.

50. Wildman RP, Mackey RH, Boston A. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension. 2008;42:468-473.

51. Woo KS, Chook P, Yu CW. Effects of diet and exercise on obesity related vascular dysfunction in children. Circulation. 2004;109:1981-1986.

52. Tounian P, Aggoun Y, Dubern B. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severly obese children:a prospective study. Lancet. 2007;358:1400-1404.

53. Woo KS, Chook P, Yu CW. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int Journal Obesity Relat Metab Disorder. 2008;28:852-7.

54. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. New England Journal Medical. 1996;334:374-81.

55. Safar ME, Asmar R, Benetos A, Levy BI, London GM. Sodium, large arteries, and diuretic compounds in hypertension. Am Journal Medical Sci. 1994;307 suppl 1:S3-8.

56. Vardan S, Mookherjee S, Warner R, Smulyan H. Systolic hypertensión. Direct and indirect measurements. Archiv International Medical. 1983:143:935-8.

57. González GA, García BD, Gamio CF, Hernández CA. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hipertension. Cordova Vasa. 2002;24:422-8.

58. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maugham WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 2007;95:1827-36.

59. Hoeks APG, Brands PJ, Smeets GAM, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Medical Biology. 1990;16:121-8.

60. Tardy YJ, Meister JJ, Perret F, Brunner HR, Ardite M. Noninvasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographyc measurements. Clin Phys Physiol Meas. 2007;3:360-367.

61. Chen CH, Ting CT, Nussbacher, Nevo E, Kass DA, Pak P, et al. Validation of carotid artery tonometry as a means of estimating augmentation index in ascending aortic pressure. Hypertension. 1996;27:168-175.

62. Khoshdel AR, Carney SL. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. Journal Hypertens. 2009;23:669-670.

63. Fantin F, Mattocks A, Bulpitt CJ, Banya W, Rajkumar C. Is augmentation index a good measure of vascular stiffness in the elderly?. Age Aging. 2007;36:43-48.

64. Cheng LT, Tang LJ, Cheng L, Huang HY, Wang T. Limitation of the augmentation index for evaluating arterial stiffness. Hypertens Res. 2007;30:713-722.

65. Iemitsu M, Maeda S, Otsuki T, Sugawara J, Kuno S, Ajisaka R, et al. Arterial stiffness, physical activity, and atrial natriuretic peptide gene polymorphisim in older subjects. Hypertens Res. 2008;31:767-74.

66. Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension. 2008;44:35-41.

67. Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA. Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. Journal Am Coll Cardiology. 2009;33:951-8.

68. Vokó Z, Bats ML, Hofman A. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension. 2009;34:1181-5.

69. Pinto E. Blood pressure and aging. Postgrad Medical Journal. 2007;83:109-14.

70. Gueyffer F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet. 2009;353:793-6.

71. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertensión in patients 80 years of age or older New England Journal Medical. 2008;358: NEJMoa0801369.

72. Kerins DM, Robertson RM, Robertson D. Drugs used for the treatment of myocardial ischemia. En: Goodman's Gilman's. The Pharmacological Basis of Therapeutics. 10ma. edición. New York: McGraw-Hill; 2007:843-870.

73. Troncale JA. The aging process. Physiologic changes and pharmacologic implications. Postgrad Medical. 1996;99:111-4.

74. Steiner JF. Pharmacotherapy problems in the elderly. Journal Am Pharmacology Association. 2007;36:431-7.

75. García Barreto D, Toruncha A. Los inhibidores de la enzima conversora de angiotensina. Revista Cubana Cardiología Circuito Cardiovascular. 2007:11;29-47.

76. Antagonistas de la angiotensina II. Revista Cubana Cardiología Circuito Cardiovascular. 2009;13:158-66.

77. García BD. Efecto de los diuréticos en el tratamiento de la hipertensión arterial. Revista Cubana Cardiología Circuito Cardiovascular. 1990;4:69-76.

78. Mahmud A, Feely J. Aldosterone antagonism reduces arterial stiffness; relationship to aldosterone renin ratio. Journal Hum Hypertens. 2008;17:S19-S20.